Pharmaceutical company QOL Medical and its CEO, Frederick Cooper, have agreed to pay $47 million to settle allegations that they violated the False Claims Act by offering kickbacks to healthcare providers to induce prescriptions for their drug Sucraid.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
